SCHEMBL20177220

SCHEMBL20177220

C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4cccc(/C=C/C(=O)N5CCC[C@@H](n6nc(-c7cnc(Oc8ccccc8)nc7)c7c(N)ncnc76)C5)c4)cn3)c3c(N)ncnc32)C1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 17/20 0.77
EGFR P00533 7/20 0.68
BMX P51813 5/20 0.68
TEC P42680 3/20 0.68
ITK Q08881 3/20 0.68
HCK P08631 3/20 0.68
SRC P12931 3/20 0.68
BLK P51451 3/20 0.68
TXK P42681 2/20 0.68
LYN P07948 2/20 0.68
FGFR2 P21802 2/20 0.68
JAK3 P52333 2/20 0.68
NUDT5 Q9UKK9 2/20 0.68
RIPK2 O43353 1/20 0.68
NR1I2 O75469 1/20 0.68
SLC22A3 O75751 1/20 0.68
LATS1 O95835 1/20 0.68
NUDT14 O95848 1/20 0.68
ABL1 P00519 1/20 0.68
ERBB2 P04626 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21330610 0.87 BTK (1.00) BTKEGFRBMXTECITK
SCHEMBL21330615 0.87 BTK (1.00) BTKEGFRBMXTECITK
SCHEMBL21330620 0.87 BTK (1.00) BTKEGFRBMXTECITK
SCHEMBL20177228 0.87 BTK (1.00) BTKEGFRBMXTECITK
SCHEMBL29702802 0.83 BTK (0.84) BTKEGFRBMXTECITK
SCHEMBL28744512 0.83 BTK (0.84) BTKEGFRBMXTECITK
Ibrutinib SCHEMBL2244865 0.82 BTK (1.00) BTKEGFRBMXTECITK
Ibrutinib SCHEMBL201859 0.82 BTK (1.00) BTKEGFRBMXTECITK
Ibrutinib SCHEMBL201641 0.82 BTK (1.00) BTKEGFRBMXTECITK
Ibrutinib SCHEMBL2244870 0.82 BTK (1.00) BTKEGFRBMXTECITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018090792-A1 SELECTIVE BRUTON'S TYROSINE KINASE INHIBITOR AND USE THEREOF 杭州和正医药有限公司 2018-05-24 WO disclosed